Immunomodulatory Care in Multiple Myeloma: Pharmacists’ Role

Here’s a list of the references​ cited in the ⁣text, formatted for clarity:

1. Mayo Clinic. lenalidomide (oral route) Description. https://www.mayoclinic.org/drugs-supplements/lenalidomide-oral-route/description/drg-20068352

2. Rehman ​W, Arfons‍ LM, ⁢Lazarus HM. The rise, ⁣fall ⁤and subsequent triumph of thalidomide: lessons learned in drug advancement. Ther Adv Hematol. 2011. doi:10.1177/2040620711413165

3. Bristol Myers Squibb REMS program.Bristol Myers Squibb. ‍Accessed December 22, 2025. https://bmsremspatientsafety.com/

4. Lenalidomide, ‍Pomalyst, and Thalomid REMS pharmacy network.bristol ‍Myers ‍Squibb. Accessed december 22, 2025. ‌ https://www.bms.com/assets/bms/us/en-us/pdf/rems-pharmacy-network.pdf